Your web browser is out of date. Update your browser for more security, speed and the best experience on this site

What we achieved

Commercialization of results from basic research since 2010

  • on average 10 awarded patents per year
  • 11 signed license agreements
  • 8 incubated projects in the area of treatment of cancer, CNS diseases, inflammation, infection and liver diseases; project iBodies

Selected partners

  • Merck Millipore – labeled nucleoside triphosphates transporting system for labeling DNA of living cells (already available on market as BioTracker™ NTP-Transporter Molecule)
  • Novo Nordisk – novel ways for the treatment of obesity and related diseases
  • Shine – a novel technology for 177-Lu isolation

Licenses to spin-offs